Home›Companies›Biotech & Pharma›NeuroDex

NeuroDex Inc

Updated Oct 27, 2026·Latest SEC filing May 2, 2023·Suggest an edit

About NeuroDex

NeuroDex is a private company based in Natick, Massachusetts, incorporated in 2018 in Delaware. It has reported $1,359,989 raised in three offerings on Form D since February 2020. Its chief executive is Oded Biran.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 14, 2023May 2, 2023$60,000of $750K target1$60,000Securities on exercise, Convertible DebtRule 506(b)Form D ↗
Aug 16, 2022Aug 30, 2022$799,989of $2.0M target3$266KEquity, OptionsRule 506(b)Form D ↗
Jan 24, 2020Feb 3, 2020$500,000fully sold1$500KEquityRule 506(b)Form D ↗
Total, three offerings$1,359,989

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NeuroDex's Form D filed May 2, 2023.

GM
Gary Magnant
Director
OB
Oded Biran
President and CEO, director
RN
Raphael Nir
Director
EE
Erez Eitan
Executive officer and director

Sources

  1. SECNeuroDex Inc filing history